Private Capital Group, LLC Aerie Pharmaceuticals Inc Transaction History

Private Capital Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 07, 2020	SELL	$11.84 - $25.52 $615 - $1,327	-52 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$17.72 - $25.1 $921 - $1,305	52 New	52 $1,000
Q3 2019 Nov 13, 2019	SELL	$18.41 - $28.0 $184 - $280	-10 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$28.97 - $48.21 $289 - $482	10 New	10 $1,000
Q3 2018 Oct 31, 2018	SELL	$56.15 - $73.9 $561 - $739	-10 Closed	0 $0
Q1 2018 May 16, 2018	SELL	$51.15 - $61.0 $7,519 - $8,967	-147 Reduced 93.63%	10 $1,000
Q4 2017 May 18, 2018	SELL	$50.85 - $65.1 $540,027 - $691,361	-10,620 Reduced 98.54%	157 $1,000
Q4 2017 Mar 07, 2018	BUY	$50.85 - $65.1 $548,010 - $701,582	10,777	10,777 $1.2 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Capital Group, LLC with notifications on news.